NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary
IR Overview News / Events / Webcasts Presentations Press Releases IR Calendar Email Alerts.
Source: pressreleasepoint.com
Stay updated with breaking news from Pathology Certification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IR Overview News / Events / Webcasts Presentations Press Releases IR Calendar Email Alerts.
NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary - read this article along with other careers information, tips and advice on BioSpace
13.12.2021 - FT MYERS, FL / ACCESSWIRE / December 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced the appointment of David Eberhard MD, PhD ... Seite 1